Prostatic Cancer Versus Androgen Deficiency

Hopital Foch1,614 enrolled

Overview

Open study to make a comparison between hypogonadism and euogonadism patients regarding the severity of prostate cancer. The purpose of this study is to determine the importance of the relationship between the hormonal status and the type of the tumor at the time of surgical intervention as well as follow up of the patients.

Study Type

INTERVENTIONAL

Allocation

Purpose

OTHER

Masking

NONE

Enrollment

1,614

Conditions

Cancer of Prostate

Interventions

Blood sampleOTHER

Eligibility

Sex: MALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male patients over than 18 years of age, with localized, stage I or II prostate cancer, not receiving local treatment (radiation, phototherapy, thermotherapy,…) or hormonal therapy, showing indication of radical prostatectomy. Exclusion Criteria: * Absence of radical prostatectomy indication * Patient received local or hormonal therapy prior to surgery * Patients already enrolled in other clinical study incompatible with the study * Patients on a treatment which can affect hormonal level (Prednisone, Ketoconazole, Abiraterone, Finasteride, Dutasteride)

Locations (8)

Clinique Saint Augustin

Bordeaux, France

Hôpitaux Civils de Colmar

Colmar, France

Hôpital Henri Mondor

Créteil, France

La Pitié-Salpêtrière (AP-HP)

Paris, France

Outcomes

Primary Outcomes

Testosteron Serum level

Time frame: The day prior to surgery

Gleason score

Time frame: 5 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.